Table 2

Marker expression in the six study groups

MarkerNormal SCJ no inflammationNormal SCJ with inflammationBOOACSSBOIMNSCJ
Mean score (range; percentage + or more).
BO, Barrett’s oesophagus; IMNSCJ, intestinal metaplasia at a normal squamo–columnar junction; OAC, oesophageal adenocarcinoma; SCJ, squamo–columnar junction; SSBO, short segment Barrett’s oesophagus.
p210.3 (0–1; 25%)0.6 (0–2; 57%)0.3 (0–1; 25%)0.8 (0–2; 58%)0.6 (0–2; 50%)0.5 (0–2; 43%)
p270.4 (0–1; 42%)0.6 (0–1; 64%)0.3 (0–1; 25%)1.1 (0–2; 92%)0.7 (0–2; 60%)1.0 (0–2; 71%)
p530.1 (0–1; 8%)0.2 (0–1; 21%)0.1 (0–1; 8%)1.5 (0–3; 67%)0.4 (0–1; 40%)0.5 (0–2; 43%)
Ki670.4 (0–1; 42%)0.9 (0–2; 71%)0.3 (0–1; 25%)1.5 (0–3; 83%)0.6 (0–1; 60%)0.6 (0–1; 57%)
Cyclin D10.5 (0–1; 50%)0.5 (0–2; 36%)0.3 (0–2; 18%)0.7 (0–2; 58%)0.4 (0–1; 40%)1.0 (0–2; 79%)
c-erbB-20.5 (0–2; 42%)0.5 (0–1; 46%)0.9 (0–2; 67%)1.2 (0–3; 64%)0.7 (0–2; 50%)0.8 (0–2; 62%)